Colorectal cancer (CRC) remains one of the most common types of cancers and a leading cause of death worldwide. Previous observational and randomised data indicated that aspirin reduced the risk of colorectal adenomas and cancer, and risk of distant metastasis for CRC. However, it is still controversial whether aspirin use before or after diagnosis could improve CRC survival.